- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01921530
Interbody vs Instrumented Posterolateral Fusion Following Decompression for Lumbar Spinal Stenosis With Degenerative Spondylolisthesis
August 17, 2018 updated by: The London Spine Centre
Interbody Fusion and Decompression Versus Instrumented Posterolateral Fusion and Decompression for Lumbar Spinal Stenosis With Degenerative Spondylolisthesis
Degenerative spondylolisthesis describes the slip of one spinal segment relative to the adjacent segment.
It is usually associated with spinal stenosis (which limits one's ability to walk and stand) and is the most common indication for surgery in adults over age 65 years.
A variety of surgical techniques are available; the most common are the Posterolateral Instrumented Fusion (PLF), and Interbody Fusion (IF) including Posterolateral Interbody Fusion (PLIF), and Transforaminal Interbody fusion (TLIF).
IF uses a cage that is placed within the cleaned out disc space between the vertebral bodies being fused.
Although this approach achieves a good fusion rate and deformity correction it is associated with a higher surgical cost and potential intra-operative complication rate.
What is more, no consensus exists as to whether IF provides better patient rated functional outcome and quality of life.
If the advantages of IF do not translate into superior patient rated outcomes, then the risk-benefit ratio would be tipped in favor of PLF.
The purpose of this study is to determine if IF is equivalent to PLF for the treatment of degenerative spondylolisthesis.
The investigators will conduct a prospective randomized control trial comparing these two procedures.
Our primary outcome measure will be the Oswestry Disability Index, which evaluates spinal pain and function.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
178
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christopher S Bailey, MD
- Phone Number: 55358 519-685-8500
- Email: Chris.Bailey@lhsc.on.ca
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6G 5L7
- Recruiting
- London Health Sciences Centre
-
Contact:
- Christopher S Bailey, MD
- Phone Number: 55358 519-685-8500
- Email: Chris.Bailey@lhsc.on.ca
-
Principal Investigator:
- Christopher S Bailey, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients aged 50 years or older
- Grade I or II (less than 50% slip of the cephalad vertebra compared to the caudal vertebra) degenerative spondylolisthesis at one or two contiguous levels between L1 and L5.
- Lumbar spinal stenosis at the same levels of the degenerative spondylolisthesis producing radiculopathy or neurogenic claudication unresponsive to a minimum of 3 months of non surgical treatment
- Patients who are medically suitable for surgical management
- Patients who have consented for surgical treatment
- Patients able to provide informed consent for the study and complete the questionnaires
Exclusion Criteria:
- Lytic spondylolisthesis
- Non degenerative stenosis (example: tumor, trauma, epidural lipomatosis)
- Severe vertical foraminal stenosis necessitating interbody insertion to re-establish foraminal height
- Segmental kyphosis at the level of the spondylolisthesis
- Segmental scoliosis >10 degrees at the level of the spondylolisthesis
- Rheumatoid arthritis
- Active infection
- On long term disability or workers compensation claim
- Drug or alcohol misuse
- Lack of permanent home residence
- Previous surgery at the proposed surgical level
- Previous fusion in the lumbar spine
- Contraindication to surgery: medical co morbidities
- Unable to complete questionnaire (e.g. Dementia)
- Unable to give voluntary consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Interbody Fusion
|
The interbody fusion (IF) procedure requires exposure and removal of the disc, curetting the end plates, inserting a cage filled with bone graft, as well as stabilization with rods and screws.
Other Names:
|
Active Comparator: Posterolateral Fusion
|
In posterolateral fusion stabilization is achieved using pedicle screws joined by rods.
The graft used to facilitate fusion is placed between decorticated transverse processes and can be an autograft of iliac bone or local bone, allograft, or a synthetic expander.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oswestry Disability Index
Time Frame: 1 year post surgery
|
The Oswestry Disability Index is an effective method of measuring disability in patients with back and leg pain and is well suited to patients who have had persistent severe disability.
It is a commonly utilized, validated, and highly reproducible.
The questionnaire can be completed in less than 5 minutes and a large amount of normative data exists.
|
1 year post surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oswestry Disability Index
Time Frame: Enrollment, and at 6 weeks, 3 months, 6 months, 2 years, 5 years and post surgery
|
The Oswestry Disability Index is an effective method of measuring disability in patients with back and leg pain and is well suited to patients who have had persistent severe disability.
It is a commonly utilized, validated, and highly reproducible.
The questionnaire can be completed in less than 5 minutes and a large amount of normative data exists.
|
Enrollment, and at 6 weeks, 3 months, 6 months, 2 years, 5 years and post surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale for back pain intensity (0-10: 0= no pain, 10=worst pain)
Time Frame: Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
|
Visual Analogue Scale for leg pain intensity (0-10: 0= no pain, 10=worst pain)
Time Frame: Enrollment and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
Enrollment and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
|
SF-12 (General Health outcome measure)
Time Frame: Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
The SF-12 is a standardized health related quality of life outcome questionnaire, which assess 8 health domains.
The physical and mental component can be derived.
It has been shown to be valid and reliable when applied to the spine patient population.
|
Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
Patient satisfaction
Time Frame: Enrollment and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
"All things considered, how satisfied are you with the results of your recent treatment for your spine fracture?
1-7, 8= not sure."
This sentence is the recommended tool for assessing global satisfaction.
|
Enrollment and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
Cost analysis
Time Frame: Enrollment, and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
Prolo economic score and cost analysis for each procedure
|
Enrollment, and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
|
Fusion rates
Time Frame: 6 months, 1 year, 5 year
|
6 months, 1 year, 5 year
|
|
Intra-operative Complication rate
Time Frame: within 6 weeks after sugery
|
within 6 weeks after sugery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christopher S Bailey, MD, The London Spine Centre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2013
Primary Completion (Anticipated)
December 1, 2018
Study Completion (Anticipated)
December 1, 2019
Study Registration Dates
First Submitted
August 9, 2013
First Submitted That Met QC Criteria
August 12, 2013
First Posted (Estimate)
August 13, 2013
Study Record Updates
Last Update Posted (Actual)
August 20, 2018
Last Update Submitted That Met QC Criteria
August 17, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 103386
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Stenosis
-
RTI SurgicalCompletedSpinal Disease | Spinal Instability | Spinal Stenosis Occipito-Atlanto-Axial | Spinal Stenosis Cervical | Spinal Stenosis Cervicothoracic RegionUnited States
-
Azienda Usl di BolognaRecruitingLumbar Spinal Stenosis | Degenerative Lumbar Spinal StenosisItaly
-
Sutherland Medical CenterActive, not recruitingSpinal Stenosis Lumbar | Spinal Canal StenosisPoland
-
Massachusetts General HospitalCompletedLumbar Spinal Stenosis | Thoracic Spinal StenosisUnited States
-
University Hospital, Basel, SwitzerlandKlinik für Radiologie und Nuklearmedizin, University Hospital BaselCompletedLumbar Spinal Stenosis | Symptomatic Lumbar Spinal StenosisSwitzerland
-
Sklifosovsky Institute of Emergency CarePirogov National Medical Surgical Center; Federal State Budgetary Institution... and other collaboratorsActive, not recruitingLumbar Spinal Stenosis | Spinal Stenosis | Spinal FusionRussian Federation
-
Region ZealandRegion SyddanmarkRecruiting
-
Tang-Du HospitalNot yet recruiting
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedLumbar Spinal StenosisTurkey
Clinical Trials on Interbody Fusion
-
Kyungpook National University HospitalUnknownDegenerative Spondylolisthesis | Transforaminal Lumbar Interbody FusionKorea, Republic of
-
ExactechTerminatedDegenerative Disc Disease | Spondylolisthesis | StenosisUnited States
-
National Taiwan University HospitalBaui Biotech Co., Ltd.RecruitingCervical Disc DegenerationTaiwan
-
Induce Biologics USA Inc.Not yet recruitingDegenerative Disc Disease | Spinal Stenosis | Degenerative SpondylolisthesisUnited States
-
University of British ColumbiaNot yet recruitingIsthmic Spondylolisthesis
-
Medtronic Spinal and BiologicsTerminatedLow Back Pain | Intervertebral Disc Displacement | Spinal Stenosis | SpondylolisthesisGermany, Netherlands
-
Mesoblast, Ltd.CompletedDegenerative Disc Disease | Spinal Stenosis | Degenerative SpondylolisthesisUnited States
-
Spine and Scoliosis Research AssociatesEnrolling by invitationDegenerative Disc Disease (DDD)United States
-
Foundation for Orthopaedic Research and EducationCoreLink, LLCCompletedDegenerative Disc Disease Lumbar
-
3SpineMCRARecruiting